Business Context and Reporting Period
This Form 8-K is a current report filed by AVROBIO, Inc. on September 21, 2018. The filing addresses a corporate governance event regarding the Board of Directors. Note: The request metadata references "Tectonic Therapeutic, Inc.," but the source text explicitly identifies the registrant as AVROBIO, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or operational metrics.
Material Changes
Departure of Director: On September 21, 2018, Joshua Resnick, M.D., resigned from the Board of Directors, effective immediately.
- Reason for Departure: Dr. Resnick is leaving SV Health Investors, an early venture capital investor in the Company, to join a fund investing in public and private equity.
- Disagreement Status: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Dr. Resnick's resignation.
- Confirm whether the Company intends to appoint a replacement director to fill the vacancy.
- Review the Company's relationship with SV Health Investors to assess any potential impact on future funding or strategic support.